Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates

Pediatric Infectious Disease Journal

Volumn 23, Issue 4, 2004, Pages 307-313

  Zhang, Qibo ^a   Arnaoutakis, Konstantinos ^a   Murdoch, Craig ^b   Lakshman, Raman ^c   Race, Gillian ^c   Burkinshaw, Roger ^c   Finn, Adam ^a,d  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

^d UBHT Education Centre   (United Kingdom)

Author keywords

Mucosal immunity; Pneumococcus; Vaccines

Indexed keywords

HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN A; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; CELL PROTECTION; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOASSAY; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MUCOSAL IMMUNITY; NOSE MUCOSA; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; VACCINATION; VIRUS DETECTION; VIRUS TRANSMISSION;

ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; COHORT STUDIES; COLONY COUNT, MICROBIAL; CONFIDENCE INTERVALS; FEMALE; HUMANS; IMMUNITY; IMMUNITY, MUCOSAL; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; MALE; MOUTH MUCOSA; NASAL MUCOSA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PROBABILITY; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; VACCINES, CONJUGATE;

EID: 1942420333     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200404000-00006     Document Type: Article

References (38)

1. King WJ, MacDonald NE, Wells G, et al. Total and functional antibody response to a quadrivalent meningoeoccal polysaccharide vaccine among children. J Pediatr 1996;128:196-202.
2. Granoff DM, Gupta RK, Belshe RB, Anderson EL. Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination. J Infect Dis 1998;178:870-4.
3. Brandt BL, Artenstein MS. Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide. J Infect Dis 1975;131(Suppl):S69-72.
4. 197 in United States infants. Pediatrics 1998; 101:604-11.
5. 197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 1999;18: 757-63.
6. Choo S, Seymour L, Morris R, et al. Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type b conjugate vaccine in United Kingdom infants. Pediatr Infect Dis J 2000;19:854-62.
7. Nurkka A, Ahman H, Korkeila M, Jantti V, Kayhty H, Eskola J. Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine PncCRM. Pediatr Infect Dis J 2001;20:25-33.
8. Nurkka A, Ahman H, Yaich M, Eskola J, Kayhty H. Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT. Vaccine 2001;20:194-201.
9. Korkeila M, Lehtonen H, Ahman H, Leroy O, Eskola J, Kayhty H. Salivary anti-capsular antibodies in infants and children immunised with Streptococcus pneumoniae capsular polysaccharides conjugated to diphtheria or tetanus toxoid. Vaccine 2000;18:1218-26.
10. Choo S, Zhang Q, Seymour L, Akhtar S, Finn A. Primary and booster salivary antibody responses to a 7-valent pneumococcal conjugate vaccine in infants. J Infect Dis 2000;182: 1260-3.
11. Dagan R, Melamed R, Muallem M, Piglansky L, Yagupsky P. Nasopharyngeal colonization in southern Israel with antibiotic-resistant pneumococci during the first 2 years of life: relation to serotypes likely to be included in pneumococcal conjugate vaccines. J Infect Dis 1996;174:1352-5.
12. Zenni MK, Cheatham SH, Thompson JM, et al. Streptococcus pneumoniae colonization in the young child: association with otitis media and resistance to penicillin. J Pediatr 1995;127: 533-7.
13. Douglas RM, Hansman D, Miles HB, Paton JC. Pneumococcal carriage and type-specific antibody: failure of a 14-valent vaccine to reduce carriage in healthy children. Am J Dis Child 1986;140:1183-5.
14. Obaro SK, Adegbola RA, Banya WA, Greenwood BM. Carriage of pneumococci after pneumococcal vaccination. Lancet 1996;348:271-2.
15. Dagan R, Melamed R, Muallem M, et al. Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 1996;174:1271-8.
16. Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P. Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 1997;16:1060-4.
17. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 1999;180:1171-6.
18. Dagan R, Fraser D. Conjugate pneumococcal vaccine and antibiotic-resistant Streptococcus pneumoniae: herd immunity and reduction of otitis morbidity. Pediatr Infect Dis J 2000;19:S79-88.
19. Lakshman R, Murdoch C, Race G, Burkinshaw R, Shaw L, Finn A. Pneumococcal nasopharyngeal carriage in children following heptavalent pneumococcal conjugate vaccination in infancy. Arch Dis Child 2003;88:211-14.
20. Zhang Q, Choo S, Finn A. Immune responses to novel pneumococcal proteins (pneumolysin, PspA, PsaA and CbpA) in adenoidal B cells from children. Infect Immun 2002;70: 5363-9.
21. Kauppi M, Saarinen L, Kayhty H. Anti-capsular polysaccharide antibodies reduce nasopharyngeal colonization by Haemophilus influenzae type b in infant rats. J Infect Dis 1993;167:365-71.
22. Kauppi-Korkeila M, van Alphen L, Madore D, Saarinen L, Kayhty H. Mechanism of antibody-mediated reduction of nasopharyngeal colonization by Haemophilus influenzae type b studied in an infant rat model. J Infect Dis 1996;174:1337-40.
23. Shurin PA, Rehmus JM, Johnson CE, et al. Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J Pediatr 1993;123:801-10.
24. Giebink GS, Koskela M, Vella PP, Harris M, Le CT. Pneumococcal capsular polysaccharide-meningococcal outer membrane protein complex conjugate vaccines: immunogenicity and efficacy in experimental pneumococcal otitis media. J Infect Dis 1993;167:347-55.
25. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001;344:403-9.
26. Simell B, Kilpi TM, Kayhty H. Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal capsular polysaccharides in children. J Infect Dis 2002;186: 1106-14.
27. Zhang Q, Choo S, Everard J, Jennings R, Finn A. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun 2000;68:2692-7.
28. O'Brien KL, Bronsdon MA, Dagan R, et al. Evaluation of a medium (STGG) for transport and optimal recovery of Streptococcus pneumoniae from nasopharyngeal secretions collected during field studies. J Clin Microbiol 2001;39:1021-4.
29. Quataert SA, Kirch CS, Wiedl LJ, et al. Assignment of weight-based antibody units to a human antipneumococcal standard reference serum, Lot 89-S. Clin Diagn Lab Immunol 1995;2:590-7.
30. Ahman H, Kayhty H, Lehtonen H, Leroy O, Froeschle J, Eskola J. Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunological memory. Pediatr Infect Dis J 1998;17:211-16.
31. Leinonen M, Sakkinen A, Kalliokoski R, Luotonen J, Timonen M, Makela PH. Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis 1986;5:39-44.
32. Makela PH, Karma P, Sipila M, Pukander J, Leinonen M. Possibilities of preventing otitis media by vaccination. Scand J Infect Dis Suppl 1983;39:34-8.
33. Kayhty H, Ahman H, Ronnberg PR, Tillikainen R, Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 1995;172:1273-8.
34. Anderson EL, Kennedy DJ, Geldmacher KM, Donnelly J, Mendelman PM. Immunogenicity of heptavalent pneumococcal conjugate vaccine in infants. J Pediatr 1996;128:649-53.
35. Obaro SK, Huo Z, Banya WAS, et al. A glycoprotein pneumococcal conjugate vaccine primes for antibody responses to a pneumococcal polysaccharide vaccine in Gambian children. Pediatr Infect Dis J 1997;16:1135-40.
36. Soininen A, Pursiainen H, Kilpi T, Kayhty H. Natural development of antibodies to pneumococcal capsular polysaccharides depends on the serotype: association with pneumococcal carriage and acute otitis media in young children. J Infect Dis 2001;184:569-76.
37. Finn A, Zhang Q, Seymour L, Fasching C, Pettitt E, Janoff EN. Induction of functional secretory IgA responses in breast milk by pneumococcal capsular polysaccharides. J Infect Dis 2002;186:1422-9.
38. Veenhoven R, Bogaert D, Uiterwaal C, et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 2003;361:2189-95.